Molecular Drug(s) of the Year

  Discoveries of Drugs that are produced basing on the intricate and accurate (and specific) molecular and cellular processes/designs that will lead to the prevention or cure of such outstanding common or rare  diseases(s). This will also include drugs of pharmacogenomics/genetics value.

  Pharmacogenomics, Pharmacogenetics and Pharmacovigilance groups among others are welcome to nominate.